BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Haggag YA, Ibrahim RR, Hafiz AA. Design, Formulation and in vivo Evaluation of Novel Honokiol-Loaded PEGylated PLGA Nanocapsules for Treatment of Breast Cancer. Int J Nanomedicine 2020;15:1625-42. [PMID: 32210557 DOI: 10.2147/IJN.S241428] [Cited by in Crossref: 30] [Cited by in F6Publishing: 32] [Article Influence: 15.0] [Reference Citation Analysis]
Number Citing Articles
1 Salah M, Sallam MA, Abdelmoneem MA, Teleb M, Elkhodairy KA, Bekhit AA, Khafaga AF, Noreldin AE, Elzoghby AO, Khattab SN. Sequential Delivery of Novel Triple Drug Combination via Crosslinked Alginate/Lactoferrin Nanohybrids for Enhanced Breast Cancer Treatment. Pharmaceutics 2022;14:2404. [DOI: 10.3390/pharmaceutics14112404] [Reference Citation Analysis]
2 Zhang X, Chen H, Zhang Y, Huang Q, Feng J, Xing H, Fu X, Yan X, Zhang Y, Xu Q, Liang J. HA-DOPE-Modified Honokiol-Loaded Liposomes Targeted Therapy for Osteosarcoma. IJN 2022;Volume 17:5137-5151. [DOI: 10.2147/ijn.s371934] [Reference Citation Analysis]
3 Sun K, Wu L, Wang S, Deng W. Antitumor effects of Chinese herbal medicine compounds and their nano-formulations on regulating the immune system microenvironment. Front Oncol 2022;12:949332. [DOI: 10.3389/fonc.2022.949332] [Reference Citation Analysis]
4 Zhang D, Liu L, Wang J, Zhang H, Zhang Z, Xing G, Wang X, Liu M. Drug-loaded PEG-PLGA nanoparticles for cancer treatment. Front Pharmacol 2022;13:990505. [DOI: 10.3389/fphar.2022.990505] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Singh P, Alka, Maurya P, Nisha R, Singh N, Parashar P, Mishra N, Pal RR, Saraf SA. QbD Assisted Development of Lipidic Nanocapsules for Antiestrogenic Activity of Exemestane in Breast Cancer. J Liposome Res 2022;:1-43. [PMID: 35930249 DOI: 10.1080/08982104.2022.2108441] [Reference Citation Analysis]
6 Ni J, Mi Y, Wang B, Zhu Y, Ding Y, Ding Y, Li X. Naturally Equipped Urinary Exosomes Coated Poly (2−ethyl−2−oxazoline)−Poly (D, L−lactide) Nanocarriers for the Pre−Clinical Translation of Breast Cancer. Bioengineering 2022;9:363. [DOI: 10.3390/bioengineering9080363] [Reference Citation Analysis]
7 Zhang H, Yu J, Ma L, Zhao Y, Xu S, Shi J, Qian K, Gu M, Tan H, Xu L, Liu Y, Mu C, Xiong Y. Reversing multi-drug resistance by polymeric metformin to enhance antitumor efficacy of chemotherapy. Int J Pharm 2022;:121931. [PMID: 35750278 DOI: 10.1016/j.ijpharm.2022.121931] [Reference Citation Analysis]
8 Atallah MA, Sallam MA, Abdelmoneem MA, Teleb M, Elkhodairy KA, Bekhit AA, Khafaga AF, Noreldin AE, Elzoghby AO, Khattab SN. Green Self-assembled Lactoferrin Carboxymethyl Cellulose Nanogels for Synergistic Chemo/herbal Breast Cancer Therapy. Colloids and Surfaces B: Biointerfaces 2022. [DOI: 10.1016/j.colsurfb.2022.112657] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
9 Ibrahim A, Khalil IA, El-Sherbiny IM. Development and evaluation of core-shell nanocarrier system for enhancing the cytotoxicity of doxorubicin/ metformin combination against breast cancer cell line. J Pharm Sci 2022:S0022-3549(22)00213-1. [PMID: 35613685 DOI: 10.1016/j.xphs.2022.05.018] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
10 Muthukrishnan L. Nanonutraceuticals — Challenges and Novel Nano-based Carriers for Effective Delivery and Enhanced Bioavailability. Food Bioprocess Technol. [DOI: 10.1007/s11947-022-02807-2] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
11 Zayed A, Haggag Y, Ezzat SM, Salem MA, Ulber R. Fucoidans as nanoparticles: pharmaceutical and biomedical applications. Polysaccharide Nanoparticles 2022. [DOI: 10.1016/b978-0-12-822351-2.00017-6] [Reference Citation Analysis]
12 Yang YY, Zhang W, Liu H, Jiang JJ, Wang WJ, Jia ZY. Cell-Penetrating Peptide-Modified Graphene Oxide Nanoparticles Loaded with Rictor siRNA for the Treatment of Triple-Negative Breast Cancer. Drug Des Devel Ther 2021;15:4961-72. [PMID: 34916779 DOI: 10.2147/DDDT.S330059] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
13 Sartaj A, Qamar Z, Qizilbash FF, Annu, Md S, Alhakamy NA, Baboota S, Ali J. Polymeric Nanoparticles: Exploring the Current Drug Development and Therapeutic Insight of Breast Cancer Treatment and Recommendations. Polymers (Basel) 2021;13:4400. [PMID: 34960948 DOI: 10.3390/polym13244400] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
14 Saha S, D'souza D, Londhe VY. Exploring the concepts of various nano-formulations loaded with herbal drugs moieties against breast cancer using PRISMA analysis. Journal of Drug Delivery Science and Technology 2021;66:102865. [DOI: 10.1016/j.jddst.2021.102865] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
15 Zhang J, Hu K, Di L, Wang P, Liu Z, Zhang J, Yue P, Song W, Zhang J, Chen T, Wang Z, Zhang Y, Wang X, Zhan C, Cheng YC, Li X, Li Q, Fan JY, Shen Y, Han JY, Qiao H. Traditional herbal medicine and nanomedicine: Converging disciplines to improve therapeutic efficacy and human health. Adv Drug Deliv Rev 2021;178:113964. [PMID: 34499982 DOI: 10.1016/j.addr.2021.113964] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 13.0] [Reference Citation Analysis]
16 Yang X, Wang Y, Chen S, Zhang S, Cui C. Cetuximab-Modified Human Serum Albumin Nanoparticles Co-Loaded with Doxorubicin and MDR1 siRNA for the Treatment of Drug-Resistant Breast Tumors. Int J Nanomedicine 2021;16:7051-69. [PMID: 34703227 DOI: 10.2147/IJN.S332830] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 6.0] [Reference Citation Analysis]
17 Chen X, Shi BL, Qi RZ, Chang X, Zheng HG. Ultra-Performance Liquid Chromatography/Mass Spectrometry-Based Metabolomics for Discovering Potential Biomarkers and Metabolic Pathways of Colorectal Cancer in Mouse Model (ApcMin/+) and Revealing the Effect of Honokiol. Front Oncol 2021;11:671014. [PMID: 34589420 DOI: 10.3389/fonc.2021.671014] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
18 Bhattacharya S. Methotrexate-loaded polymeric lipid hybrid nanoparticles (PLHNPs): a reliable drug delivery system for the treatment of glioblastoma. Journal of Experimental Nanoscience 2021;16:344-67. [DOI: 10.1080/17458080.2021.1983172] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 8.0] [Reference Citation Analysis]
19 Yang Y, Feng Q, Ding C, Kang W, Xiao X, Yu Y, Zhou Q. Controllable Drug Delivery by Na+/K+ ATPase α1 Targeting Peptide Conjugated DSPE-PEG Nanocarriers for Breast Cancer. Technol Cancer Res Treat 2021;20:15330338211027898. [PMID: 34180301 DOI: 10.1177/15330338211027898] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
20 Engelberg S, Lin Y, Assaraf YG, Livney YD. Targeted Nanoparticles Harboring Jasmine-Oil-Entrapped Paclitaxel for Elimination of Lung Cancer Cells. Int J Mol Sci 2021;22:1019. [PMID: 33498454 DOI: 10.3390/ijms22031019] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 8.0] [Reference Citation Analysis]
21 Haggag YA, Abosalha AK, Tambuwala MM, Osman EY, El-Gizawy SA, Essa EA, Donia AA. Polymeric nanoencapsulation of zaleplon into PLGA nanoparticles for enhanced pharmacokinetics and pharmacological activity. Biopharm Drug Dispos 2021;42:12-23. [PMID: 33320969 DOI: 10.1002/bdd.2255] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 10.0] [Reference Citation Analysis]